Skip to main content
OpenTrials
Completed

NCT Number: NCT01594775

Oxytocin, Couple Interaction and Wound Healing

effects of intranasal oxytocin and couple interaction on wound healing.

* Trial with medicinal product

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

21 year–45 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1

Primary location

University Hospital Zurich, Dept. of Dermatology

Zurich, 8091, Switzerland

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • healthy heterosexual couples
  • in a stable relationship since > 1 year

Exclusion criteria

pregnancy

  • breast feeding
  • heavy smoking (> 5 cigarettes/d)
  • extensive skin disease
  • artificial UV irradiation during < 3 months before study inclusion

Treatment and study plan

Syntocinon (Oxytocin) nasal spray

Drug

two-times daily self-administration of nasal spray containing active substance (oxytocin) during five days after wounding.

Placebo

Drug

two-times daily self-administration of nasal spray containing placebo during five days after wounding.

Primary outcomes

  1. wound size

    Time frame: seven days

    wound healing process within seven days after wounding

Sponsors and collaborators

Lead sponsor

University of Zurich

Other

Collaborators

  • Swiss National Science Foundation

Registry information

Important dates

Study start
2011
Primary completion
2013
Study completion
2013
First posted
May 9, 2012
Registry last updated
Feb 25, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.